An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

NCT01739348 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2211

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Verubecestat (Part I and Part II)
DRUG: Verubecestat (Part I and Part II)
DRUG: Verubecestat (Part I and Part II)
DRUG: Placebo (Part I)
DRUG: Verubecestat (Part II)

Sponsor

Merck Sharp & Dohme LLC